Page 97 - Read Online

Page 423 Gutierrez et al. Cancer Drug Resist 2021;4:414-23 I http://dx.doi.org/10.20517/cdr.2020.113

52. Yamato I, Sho M, Shimada K, et al. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and
angiogenesis. Cancer Res 2012;72:4829-39.
53. Stefansson OA, Hermanowicz S, van der Horst J, et al. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast
cancer. BMC Cancer 2017;17:469.
54. Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R. The DNA repair protein ALKBH2 mediates temozolomide
resistance in human glioblastoma cells. Neuro Oncol 2013;15:269-78.
55. Konishi N, Nakamura M, Ishida E, et al. High expression of a new marker PCA-1 in human prostate carcinoma. Clin Cancer Res
2005;11:5090-7.
56. Liu BQ, Wu YD, Li PH, Wei JX, Zhang T, Liu RL. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Asian J
Androl 2007;9:821-6.
57. Wang P, Dong Q, Zhang C, et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and
share hypermethylation targets with glioblastomas. Oncogene 2013;32:3091-100.
58. Yang H, Ye D, Guan KL, Xiong Y. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin
Cancer Res 2012;18:5562-71.
59. Schaap FG, French PJ, Bovée JV. Mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 in tumors. Adv Anat Pathol
2013;20:32-8.
60. Wang P, Wu J, Ma S, et al. Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant
Cells to Alkylating Agents. Cell Rep 2015;13:2353-61.
61. Tran TQ, Ishak Gabra MB, Lowman XH, et al. Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to
alkylating agents through inhibition of ALKBH enzymes. PLoS Biol 2017;15:e2002810.
62. Voigt JM, Topal MD. O6-methylguanine-induced replication blocks. Carcinogenesis 1995;16:1775-82.